[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Hospital St. Joseph, Marseille, France\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":85},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,40,64],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":39},"100441358","efficacy-of-preparation-in-self-hypnosis-by-anchoring-versus-conversational-hypnosis-used-alone-or-combined-in-patients-undergoing-breast-macrobiopsies-100441358",false,"NCT05027321","Efficacy of Preparation in Self-Hypnosis by Anchoring Versus Conversational Hypnosis, Used Alone or Combined, in Patients Undergoing Breast Macrobiopsies","Efficacy of Preparation in Self-Hypnosis by Anchoring Versus Conversational Hypnosis, Used Alone or Combined, in Patients Undergoing Breast Macrobiopsies: a Randomized Study","Inclusion Criteria:\n\n* aged 18 or over,\n* referred to the medical imaging department of Saint-Joseph hospital for breast macrobiopsy,\n* naive of any hypnosis,\n* having given free, informed and written consent,\n* being affiliated to a social security scheme or beneficiary of such scheme\n\nExclusion Criteria:\n\n* having a major hearing loss,\n* suffering from identified mental or psychotic disorders,\n* not understanding the French language,\n* having already had hypnosis practices,\n* having an ongoing pregnancy,\n* being the subject of a safeguard measure","FEMALE","18 Years",{"count":19,"type":20},100,"ESTIMATED","INTERVENTIONAL",[23],"NA","The incidence of breast cancer and its mortality are reduced thanks in particular to early detection.\n\nOften performed after a screening test, stereotactic macrobiopsies are used to characterize abnormalities detected on mammography. This anxiety-inducing and painful examination leads to significant physiological and psychological modifications for these women who logically apprehend the realization of this act.\n\nFaced with this observation, investigators wondered what could be done to improve the experience of the patients during this examination.\n\nInvestigators were interested in hypnosis because its effectiveness as a complementary practice has been validated by numerous studies with benefits on pain and stress management.\n\nHowever, today, there are no convincing results confirming which hypnosis method would be the best to manage patients' anxiety and pain during this examination.",[26],"Breast Neoplasm Female","RECRUITING","2024-09-12",{"date":30,"type":31},"2024-09-19","ACTUAL",{"date":33,"type":31},"2022-10-11",{"date":35,"type":20},"2025-01",{"name":37,"class":38},"Hospital St. Joseph, Marseille, France","OTHER",1,{"id":41,"slug":42,"hasResults":11,"nctId":43,"briefTitle":44,"officialTitle":45,"acronym":4,"eligibilityCriteria":46,"healthyVolunteers":11,"sex":47,"minAge":48,"maxAge":49,"enrollmentInfo":50,"targetDuration":4,"studyType":21,"phases":52,"briefSummary":53,"conditions":54,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":39},"100476631","evaluation-of-lung-cancer-ct-screening-performance-among-former-and-current-smokers-100476631","NCT05486455","Evaluation of Lung Cancer CT Screening Performance Among Former and Current Smokers","Evaluation of Lung Cancer CT Screening Performance Among Former and Current Smokers: a \"Real Life\" Study","Inclusion Criteria:\n\n* Male or female 50-80 years old\n* Active smoker (≥ 15 PA) or former smoker (≥ 15 PA)\n\nExclusion Criteria:\n\n* Recent history of chest CT scan (within 12 months)\n* Person unable to climb 2 floors\n* Weight \\> 140kg\n* Personal history of cancer \\\u003C 5 years (currently being monitored by thoracic imaging)","ALL","50 Years","80 Years",{"count":51,"type":20},1000,[23],"Diagnostic performance of low-dose chest CT scan combined with lung-RADS classification (version 1.1) for lung cancer screening among former and current smokers.",[55],"Smoking","2022-12-02",{"date":58,"type":31},"2022-12-06",{"date":60,"type":31},"2022-11-04",{"date":62,"type":20},"2028-10",{"name":37,"class":38},{"id":65,"slug":66,"hasResults":11,"nctId":67,"briefTitle":68,"officialTitle":69,"acronym":4,"eligibilityCriteria":70,"healthyVolunteers":11,"sex":47,"minAge":17,"maxAge":49,"enrollmentInfo":71,"targetDuration":4,"studyType":21,"phases":72,"briefSummary":73,"conditions":74,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},"100434579","interest-of-the-immunoscore-as-a-post-operative-complementary-tool-for-the-detection-of-the-risk-of-recurrence-in-patients-with-nonmetastatic-colorectal-cancer-100434579","NCT04938986","Interest of the Immunoscore® as a Post-operative Complementary Tool for the Detection of the Risk of Recurrence in Patients With Nonmetastatic Colorectal Cancer","Interest of the Immunoscore® as a Post-operative Complementary Tool for the Detection of the Risk of Recurrence in Patients With Nonmetastatic Colorectal Cancer : Prospective Cohort Comparing the Recommandation for Patient Care According to the Immunoscore® With the Standard Care Decision.","Inclusion Criteria:\n\n* age between 18 and 80 inclusive;\n* histologically confirmed colon adenocarcinoma;\n* having undergone a curative resection of stage I, II or III colorectal cancer;\n* diagnosed T1 \u002F T2 \u002F T3 \u002F T4 and N0 \u002F N1 \u002F N2;\n* eligible to receive 6 months of adjuvant chemotherapy;\n* having given free, informed and written consent;\n* agreeing to the use of a tumor sample for research purposes;\n* being affiliated to a social security system.\n\nExclusion Criteria:\n\n* pregnant or breastfeeding women\n* legal incapacity or physical, psychological, social or geographical conditions preventing the patient from signing the consent or completing the study.\n* history of other solid tumor within 3 years before inclusion, with the exception of in-situ cancer of the cervix and skin cancers (basal or squamous) treated and controlled\n* person subject to a safeguard measure.",{"count":19,"type":20},[23],"Evaluate the patient care recommandation induced by the IMMUNOSCORE® result",[75],"Non Metastatic Colorectal Cancer","2022-04-12",{"date":78,"type":31},"2022-04-13",{"date":80,"type":31},"2022-04-04",{"date":82,"type":20},"2028-04",{"name":37,"class":38},2,""]